Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
DOCUSATE SODIUM | PRO DOC LIMITEE | Actual shortage | 100MG | Updated Report | 2024-12-04 | 241984 |
DEPO-MEDROL 80 MG/ML | PFIZER CANADA ULC | Anticipated shortage | 80MG | Updated Report | 2024-12-04 | 242131 |
MDK-NITISINONE | MENDELIKABS INC | Anticipated shortage | 5MG | Updated Report | 2024-12-04 | 239658 |
M-ESLON | ETHYPHARM INC | Anticipated shortage | 200MG | New Report | 2024-12-04 | 244743 |
TAMSULOSIN CR | SANIS HEALTH INC | Actual shortage | 0.4MG | Updated Report | 2024-12-04 | 230839 |
PRAMIPEXOLE | SANIS HEALTH INC | Actual shortage | 0.25MG | Updated Report | 2024-12-04 | 242419 |
GABAPENTIN | SANIS HEALTH INC | Actual shortage | 300MG | Updated Report | 2024-12-04 | 243265 |
BETAHISTINE | SANIS HEALTH INC | Actual shortage | 24MG | New Report | 2024-12-04 | 244732 |
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% | OMEGA LABORATORIES LIMITED | Resolved | 10MG | Updated Report | 2024-12-04 | 157872 |
NALOXONE HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | Resolved | 1MG | Updated Report | 2024-12-04 | 102929 |
NALOXONE HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | Resolved | 0.4MG | Updated Report | 2024-12-04 | 102920 |
RITUXAN SC | HOFFMANN-LA ROCHE LIMITED | Resolved | 1400MG | Updated Report | 2024-12-04 | 243448 |
MONTELUKAST | SANIS HEALTH INC | Resolved | 5MG | Updated Report | 2024-12-04 | 76275 |
MONTELUKAST | SANIS HEALTH INC | Resolved | 5MG | Updated Report | 2024-12-04 | 81977 |
LEUCOVORIN CALCIUM INJECTION USP | PFIZER CANADA ULC | Resolved | 10MG | Updated Report | 2024-12-04 | 220361 |
METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Actual shortage | 25MG | Updated Report | 2024-12-04 | 239730 |
AURO-VALSARTAN HCT | AURO PHARMA INC | Actual shortage | 12.5MG 160MG | Updated Report | 2024-12-04 | 235918 |
ATOVAQUONE PROGUANIL | SANIS HEALTH INC | Resolved | 100MG 250MG | Updated Report | 2024-12-04 | 236964 |
AA-THEO LA | AA PHARMA INC | Actual shortage | 200MG | Updated Report | 2024-12-04 | 244126 |
VENLAFAXINE XR | JAMP PHARMA CORPORATION | Actual shortage | 75MG | Updated Report | 2024-12-03 | 183736 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
LAMISIL | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 250MG | Updated Report | 2024-11-28 | 244096 |
FLAREX | NOVARTIS PHARMACEUTICALS CANADA INC | Discontinued | 0.1% | Updated Report | 2024-11-28 | 235987 |
ERFA-AMIKACIN | SEARCHLIGHT PHARMA INC | Discontinued | 250MG | New Report | 2024-11-27 | 243998 |
HUMALOG | ELI LILLY CANADA INC | To be discontinued | 100UNIT | Updated Report | 2024-11-27 | 224347 |
MICAFUNGIN SODIUM FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Discontinued | 100MG | Updated Report | 2024-11-26 | 243753 |
FLAGYL | SANOFI-AVENTIS CANADA INC | Discontinued | 10% | Updated Report | 2024-11-20 | 223877 |
INVOKAMET | JANSSEN INC | Discontinued | 500MG 150MG | Updated Report | 2024-11-13 | 230850 |
PEDIACEL | SANOFI PASTEUR LIMITED | Discontinued | 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG | Updated Report | 2024-11-11 | 206912 |
AUBAGIO | SANOFI-AVENTIS CANADA INC | Discontinued | 14MG | Updated Report | 2024-11-09 | 226847 |
GAVRETO | HOFFMANN-LA ROCHE LIMITED | To be discontinued | 100MG | New Report | 2024-11-06 | 242142 |
AERMONY RESPICLICK | TEVA CANADA LIMITED | Discontinued | 55MCG | New Report | 2024-11-05 | 242101 |
DORZOLAMIDE AND TIMOLOL EYE DROPS BP | HIKMA CANADA LIMITED | Discontinued | 5MG 20MG | New Report | 2024-11-01 | 241852 |
PEDIACEL | SANOFI PASTEUR LIMITED | Discontinued | 5MCG 20MCG 30MCG 10MCG 26UNIT 7UNIT 29UNIT 5LF 15LF 20MCG 3MCG | New Report | 2024-11-01 | 241815 |
DALACIN C 300 MG | PFIZER CANADA ULC | Discontinued | 300MG | Updated Report | 2024-10-30 | 241493 |
PANTOPRAZOLE SODIUM FOR INJECTION | SANDOZ CANADA INCORPORATED | Discontinued | 40MG | New Report | 2024-10-29 | 241520 |
IMDUR | JUNO PHARMACEUTICALS CORP. | Discontinued | 60MG | Updated Report | 2024-10-29 | 233587 |
TD ADSORBED | SANOFI PASTEUR LIMITED | Discontinued | 5LF 2LF | Updated Report | 2024-10-25 | 206909 |
HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 24MG 3.15ML | New Report | 2024-10-18 | 240682 |
HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 12MG 3.15ML | New Report | 2024-10-18 | 240679 |
HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 6MG 3.15ML | New Report | 2024-10-18 | 240676 |